Order Article Reprints

Ferrante M, Leite BMM, Fontes LBC, Santos Moreira A, Nascimento de Almeida ÉM, Brodskyn CI, Lima IdS, dos Santos WLC, Pacheco LV, Cardoso da Silva V, et al. Pharmacokinetics, Dose-Proportionality, and Tolerability of Intravenous Tanespimycin (17-AAG) in Single and Multiple Doses in Dogs: A Potential Novel Treatment for Canine Visceral Leishmaniasis. Pharmaceuticals. 2024; 17(6):767. https://doi.org/10.3390/ph17060767

Ferrante, Marcos, Bruna Martins Macedo Leite, Lívia Brito Coelho Fontes, Alice Santos Moreira, Élder Muller Nascimento de Almeida, Claudia Ida Brodskyn, Isadora dos Santos Lima, Washington Luís Conrado dos Santos, Luciano Vasconcellos Pacheco, Vagner Cardoso da Silva, and et al. 2024. "Pharmacokinetics, Dose-Proportionality, and Tolerability of Intravenous Tanespimycin (17-AAG) in Single and Multiple Doses in Dogs: A Potential Novel Treatment for Canine Visceral Leishmaniasis" Pharmaceuticals 17, no. 6: 767. https://doi.org/10.3390/ph17060767

Ferrante, M., Leite, B. M. M., Fontes, L. B. C., Santos Moreira, A., Nascimento de Almeida, É. M., Brodskyn, C. I., Lima, I. d. S., dos Santos, W. L. C., Pacheco, L. V., Cardoso da Silva, V., dos Anjos, J. P., Guarieiro, L. L. N., Landoni, F., de Menezes, J. P. B., Fraga, D. B. M., Santos Júnior, A. d. F., & Veras, P. S. T. (2024). Pharmacokinetics, Dose-Proportionality, and Tolerability of Intravenous Tanespimycin (17-AAG) in Single and Multiple Doses in Dogs: A Potential Novel Treatment for Canine Visceral Leishmaniasis. Pharmaceuticals, 17(6), 767. https://doi.org/10.3390/ph17060767